Literature DB >> 35080781

The cardioprotective effects of nano-curcumin against doxorubicin-induced cardiotoxicity: A systematic review.

Hossein Moutabian1, Ruhollah Ghahramani-Asl2, Tohid Mortezazadeh3, Reza Laripour1, Asghar Narmani4, Hamed Zamani5, Gholamreza Ataei6, Hamed Bagheri1,7, Bagher Farhood8,9, Thozhukat Sathyapalan10, Amirhossein Sahebkar11,12,13,14,15.   

Abstract

Although the chemotherapeutic drug, doxorubicin, is commonly used to treat various malignant tumors, its clinical use is restricted because of its toxicity especially cardiotoxicity. The use of curcumin may alleviate some of the doxorubicin-induced cardiotoxic effects. Especially, using the nano-formulation of curcumin can overcome the poor bioavailability of curcumin and enhance its physicochemical properties regarding its efficacy. In this study, we systematically reviewed the potential cardioprotective effects of nano-curcumin against the doxorubicin-induced cardiotoxicity. A systematic search was accomplished based on Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for the identification of all relevant articles on "the role of nano-curcumin on doxorubicin-induced cardiotoxicity" in the electronic databases of Scopus, PubMed, and Web of Science up to July 2021. One hundred and sixty-nine articles were screened following a predefined set of inclusion and exclusion criteria. Ten eligible scientific papers were finally included in the present systematic review. The administration of doxorubicin reduced the body and heart weights of mice/rats compared to the control groups. In contrast, the combined treatment of doxorubicin and nano-curcumin increased the body and heart weights of animals compared with the doxorubicin-treated groups alone. Furthermore, doxorubicin could significantly induce the biochemical and histological changes in the cardiac tissue; however, coadministration of nano-curcumin formulation demonstrated a pattern opposite to the doxorubicin-induced changes. The coadministration of nano-curcumin alleviates the doxorubicin-induced cardiotoxicity through various mechanisms including antioxidant, anti-inflammatory, and antiapoptotic effects. Also, the cardioprotective effect of nano-curcumin formulation against doxorubicin-induced cardiotoxicity was higher than free curcumin.
© 2022 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cardioprotection; cardiotoxicity; curcumin; doxorubicin; nanoparticle; neoplasms

Mesh:

Substances:

Year:  2022        PMID: 35080781     DOI: 10.1002/biof.1823

Source DB:  PubMed          Journal:  Biofactors        ISSN: 0951-6433            Impact factor:   6.113


  3 in total

Review 1.  Potential of Ferritin-Based Platforms for Tumor Immunotherapy.

Authors:  Xiaoling Xu; Kewei Tian; Xuefang Lou; Yongzhong Du
Journal:  Molecules       Date:  2022-04-22       Impact factor: 4.927

Review 2.  A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.

Authors:  Hossein Moutabian; Mehrsa Majdaeen; Ruhollah Ghahramani-Asl; Masoumeh Yadollahi; Esmaeil Gharepapagh; Gholamreza Ataei; Zahra Falahatpour; Hamed Bagheri; Bagher Farhood
Journal:  Cancer Cell Int       Date:  2022-04-02       Impact factor: 5.722

Review 3.  Ibrutinib-Associated Cardiotoxicity: From the Pharmaceutical to the Clinical.

Authors:  Rong Dong; Youyou Yan; Xiaokang Zeng; Nengming Lin; Biqin Tan
Journal:  Drug Des Devel Ther       Date:  2022-09-20       Impact factor: 4.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.